Left ventricular assist device (LVAD) therapy is a lifesaving option for patients with medical
therapy-refractory advanced heart failure. Depending on the definition, 5–44% of people …

The ProtekDuo, single site dual lumen cannula can be used in a multitude of configurations.
In the medical literature, the ProtekDuo is described as right ventricular assist device …

Aim The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left
ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over …

Acute right-sided heart failure (RHF) is a complex clinical syndrome, with a wide range of
clinical presentations, associated with increased mortality and morbidity, but about which …

Despite advancing technology, right heart failure after left ventricular assist device
implantation remains a significant source of morbidity and mortality. With the UNOS …

One of the most challenging and prevalent side effects of LVAD implantation is that of right
heart failure (RHF) that may develop afterwards. The purpose of this study is to review and …

Abstract Purpose of Review Describe disparities in diagnosis and management between
men and women with advanced heart failure (HF). Our goal is to identify barriers and …

Right heart failure (RHF) is a severe complication after left ventricular assist device (LVAD)
implantation. The aim of this study was to analyze the incidence, risk factors, and biomarkers …

The development of the latest generation of durable left ventricular assist devices (LVAD)
drastically decreased adverse events such as pump thrombosis or disabling strokes …

Right heart failure (RHF) following implantation of a left ventricular assist device (LVAD) is a
common and potentially serious condition with a wide spectrum of clinical presentations with …